Lung Cancer Patients Live Longer With Immune Therapy – New York Times
New York Times |
Lung Cancer Patients Live Longer With Immune Therapy
New York Times The findings should change medical practice immediately, cancer experts say: Patients with this type of lung cancer should receive an immune-activating drug, also called immunotherapy, as early as possible after the diagnosis is made. “What it suggests … |
